Acadia Healthcare (ACHC) Tops Q3 EPS by 1c, Misses on Revenue; Offers FY24 Guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q3 EPS of $0.91, $0.01 better than the analyst estimate of $0.90. Revenue for the quarter came in at $815.6 million versus the consensus estimate of $819.39 million.

GUIDANCE:

Acadia Healthcare sees FY2024 EPS of $3.35-$3.45, versus the consensus of $3.52. Acadia Healthcare sees FY2024 revenue of $3.15-3.165 billion, versus the consensus of $3.2 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
• FDA grants accelerated approval to AstraZeneca's camizestrant combo